Browse by author
Lookup NU author(s): Professor Majlinda Lako,
Professor Miodrag Stojkovic
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© Springer Science+Business Media Dordrecht 2013.Mesenchymal stem cells (MSCs) are self-renewing cells with multipotent differentiation characteristics and capability for the regulation of immune response. Accordingly, in the context of diabetes research, the ability of MSC to generate insulin-producing cells and to enhance islet engraftment and survival makes them attractive as new therapeutic agents for treatment of diabetes and related complications. In this chapter we emphasized the role of MSCs in the repair of cell mass and function and we described the capacity of MSCs to modulate the autoimmune response during the pathogenesis of diabetes mellitus. In addition, we also presented here the mechanisms, promises and potential obstacles for MSC therapy of diabetic complications: cardiomyopathy, critical limb ischemia, nephropathy, polyneuropathy, retinopathy and diabetic wounds.
Author(s): Volarevic V, Lako M, Stojkovic M
Editor(s): Robert Chunhua Zhao
Publication type: Book Chapter
Publication status: Published
Book Title: Essentials of Mesenchymal Stem Cell Biology and Its Clinical Translation
Online publication date: 29/04/2013
Place Published: Dordrecht
Library holdings: Search Newcastle University Library for this item